Treatment response for late-life generalized anxiety disorder: Moving beyond symptom-based measures

Journal of Nervous and Mental Disease

Volumn 199, Issue 10, 2011, Pages 811-814

  Roseman, Ashley S ^a,b   Cully, Jeffrey A ^a,b,c,d   Kunik, Mark E ^a,b,c,d   Novy, Diane M ^e   Rhoades, Howard M ^f   Wilson, Nancy L ^a,b   Bush, Amber L ^a,g   Stanley, Melinda A ^a,b,d  

^a VA HSRandD Center of Excellence   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Education   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g UNIVERSITY OF HOUSTON   (United States)

Author keywords

Generalized anxiety disorder; older adults; quality of life; treatment response

Indexed keywords

ARTICLE; BECK ANXIETY INVENTORY; DAILY LIFE ACTIVITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GENERAL CONDITION IMPROVEMENT; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; QUALITY OF LIFE; TREATMENT RESPONSE;

AGED; ANXIETY DISORDERS; COGNITIVE THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 80053529499     PISSN: 00223018     EISSN: 1539736X     Source Type: Journal    
DOI: 10.1097/NMD.0b013e31822feda6     Document Type: Article

References (32)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th ed, text revision).Washington, DC: American Psychiatric Association.
2. Beck AT, Steer RA (1990) Beck Anxiety Inventory: Manual. San Antonio, TX: The Psychological Corporation.
3. Blazer D, George LK, Hughes D (1991) The epidemiology of anxiety disorders: An age comparison. In C Salazman, BD, Lebowitz (Eds), Anxiety in the elderly: Treatment and research (pp 17-30). New York: Springer Publishing.
4. Bourland SL, Stanley MA, Snyder AG, Novy DM, Beck JG, Averill PM, Swann AC (2000) Quality of life in older adults with generalized anxiety disorder. Aging Ment Health. 4:315-323.
5. Brenes GA, Miller ME, Stanley MA, Williamson JD, Knudson M, McCall WV (2009) Insomnia in older adults with generalized anxiety disorder. Am J Geriatr Psychiatry. 17:465-472.
6. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state": A practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:189-198.
7. Frisch MB, Cornell J, Villanueva M, Retzlaff PJ (1992) Clinical validation of the Quality of Life Inventory: A measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess. 4:92-101.
8. Guy W (1976) ECDEU Assessment manual for psychopharmacology, revised. Rockville, MD: US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs. (DHEW Publ No ADM 76-338)
9. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol. 32:50-55.
10. Hopko DR, Stanley MA, Reas DL, Wetherell JL, Beck JG, Novy DM, Averill PM (2003) Assessing worry in older adults: Confirmatory factor analysis of the Penn State Worry Questionnaire and psychometric properties of an abbreviated model. Psychol Assess. 15:173-183. (Pubitemid 36750525)
11. Jacobson NS, Truax P (1991) Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 59:12-19.
12. Jaeschke R, Singer J, Guyatt GH (1989) Measurement of health status: Ascertaining the minimal clinically important difference. Control Clin Trials. 10:407-415. (Pubitemid 20025670)
13. Kabacoff RI, Segal DL, Hersen M, Van Hasselt VB (1997) Psychometric properties and diagnostic utility of the Beck Anxiety Inventory and State-Trait Anxiety Inventory with older adult psychiatric outpatients. J Anxiety Disord. 11:33-47. (Pubitemid 27199171)
14. Katz IR, Reynolds CF, Alexopoulous GS, Hackett D (2002) Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: Pooled analysis of five randomized placebo-controlled clinical trials. J Am Geriatr Soc. 50: 18-25. (Pubitemid 34053018)
15. Kazdin AE (1999) The meanings and measurement of clinical significance. J Consult Clin Psychol. 67:332-339. (Pubitemid 29266502)
16. Kessler R (2000) The epidemiology of pure and comorbid generalized anxiety disorder: A review and evaluation of recent research. Acta Psychiatr Scand. 102:7-13.
17. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. 33:159-174. (Pubitemid 8054849)
18. Lenze EJ, Mulsant BH, Shear MK, Dew MA, Miller MD, Pollock BG, Houck P, Tracey B, Reynolds DF III (2005) Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: Results from an 8-week randomized, placebo-controlled trial. Am J Psychiatry. 162:146-150. (Pubitemid 40095684)
19. Lenze EJ, Rollman BL, Shear MK, Dew MA, Pollock RG, Ciliberti C, Constantino M, Snyder S, Shi P, Spitznagel E, Andreescu C, Butters MA, Reynolds DF III (2009) Escitalopram for older adults with generalized anxiety disorder: A randomized controlled trial. JAMA. 301:295-303.
20. Meyer TJ, Miller ML, Metzger RL, Borkovec TD (1990) Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 28: 487-495.
21. Pinquart M, Duberstein PR (2007) Treatment of anxiety disorders in older adults: A meta-analytic comparison of behavioral and pharmacological interventions. Am J Geriatr Psychiatry. 15:639-651.
22. Porenskey EK, Dew MA, Karp JF, Skidmore E, Rollman BL, Shear MK, Lenze EJ (2009) The burden of late-life generalized anxiety disorder: Effects on disability, health-related quality of life, and healthcare utilization. Am J Geriatr Psychiatry. 17:473-482.
23. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM (2001) Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 13:166-178. (Pubitemid 32550226)
24. Shear K, Belnap BH, Mazumdar S, Houck P, Rollman B (2006) Generalized anxiety disorder severity scale (GADSS): A preliminary validation study. Depress Anxiety. 23:77-82.
25. Spitzer RL, Williams JB, Gibbon M, First MB (1992) The Structured Clinical Interview for DSM-III-R (SCID) I: History, rationale, and description. Arch Gen Psychiatry. 49:624-629.
26. Stanley MA, Beck JG, Novy DM, Averill PM, Swann AC, Diefenbach GJ, Hopko DR (2003) Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol. 71:309-319. (Pubitemid 36323935)
27. Stanley MA, Wilson NL, Novy DM, Rhoades HM, Wagener PD, Greisinger AJ, Cully JA, Kunik ME (2009) Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: A randomized clinical trial. JAMA. 301:1460-1467.
28. Ware JE Jr, Sherbourne CD (1992) The MOS 36-Item Short Form Health Survey (SF-36), I: Conceptual framework and item selection. Med Care. 30:473-483.
29. Weiss BJ, Calleo J, Rhoades H, Novy DM, Kunik ME, Lenze EJ, Stanley MA (2009) The utility of the Generalized Anxiety Disorder Severity Scale (GADSS) with older adults in primary care. Depress Anxiety. 26:31-40.
30. Weissman MM, Olfson M, Gameroff JJ, Feder A, Fuentes M (2001) A comparison of three scales for assessing social functioning in primary care. Am J Psychiatry. 158:460-466. (Pubitemid 32205205)
31. Wetherell JL, Gatz M, Craske MG (2003) Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol. 71:31-40. (Pubitemid 36150947)
32. Wetherell JL, Hopko DR, Diefenbach GJ, Averill PM, Beck JG, Craske MG, Gatrz M, Novy DM, Stanley MA (2005) Cognitive-behavioral therapy for late-life generalized anxiety disorder: Who gets better? Behav Ther. 36: 147-156.